A detailed history of Flputnam Investment Management CO transactions in Viatris Inc stock. As of the latest transaction made, Flputnam Investment Management CO holds 3,064 shares of VTRS stock, worth $34,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,064
Previous 802 282.04%
Holding current value
$34,316
Previous $8,000 337.5%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$10.32 - $12.13 $23,343 - $27,438
2,262 Added 282.04%
3,064 $35,000
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $8,060 - $9,640
802 New
802 $8,000
Q3 2023

Nov 06, 2023

SELL
$9.59 - $11.35 $5,495 - $6,503
-573 Reduced 3.24%
17,111 $168,000
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $1,930 - $2,202
214 Added 1.22%
17,684 $176,000
Q1 2023

Apr 27, 2023

BUY
$9.2 - $12.26 $6,007 - $8,005
653 Added 3.88%
17,470 $168,000
Q4 2022

Jan 31, 2023

BUY
$8.72 - $11.56 $30,807 - $40,841
3,533 Added 26.6%
16,817 $187,000
Q3 2022

Nov 07, 2022

SELL
$8.48 - $11.13 $754 - $990
-89 Reduced 0.67%
13,284 $113,000
Q2 2022

Aug 08, 2022

SELL
$9.95 - $12.27 $2,825 - $3,484
-284 Reduced 2.08%
13,373 $140,000
Q1 2022

Apr 28, 2022

SELL
$9.81 - $15.4 $1,500 - $2,356
-153 Reduced 1.11%
13,657 $149,000
Q4 2021

Feb 15, 2022

SELL
$12.09 - $14.68 $2,272 - $2,759
-188 Reduced 1.34%
13,810 $187,000
Q3 2021

Oct 26, 2021

SELL
$13.25 - $15.13 $569 - $650
-43 Reduced 0.31%
13,998 $190,000
Q2 2021

Aug 11, 2021

SELL
$12.97 - $16.15 $215,379 - $268,186
-16,606 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $19,950 - $27,216
-1,468 Reduced 8.12%
16,606 $232,000
Q4 2020

Feb 02, 2021

BUY
$14.3 - $18.74 $258,458 - $338,706
18,074 New
18,074 $339,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Flputnam Investment Management CO Portfolio

Follow Flputnam Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flputnam Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Flputnam Investment Management CO with notifications on news.